ISSN (On-line) 1678-2925
Home
About
Brief History
Open Science Compliance
Publication Ethics
Focus and Scope
Digital Preservation
Editorial Policy
Ethics Committee
Copyright License
Technical Team
More Metrics
Issues
Current Issue
Previous
Supplements
COMMENTED PAPERS - EDITORS CHOICE
Advanced Search
Editorial Board
Editorial Board
Administrative Board
Submission
Instructions to Authors
Submission of articles
Required Documents
Editorial Responsibilities
Charges Fees
Conflict of interest
Media
Videos
Podcasts
Contact
Home
Past Issues
Summary Vol.89 Issue
1 / 2026
Article
Article
Send this article by email
COMMENTED PAPERS - EDITORS CHOICE
Low-dose valacyclovir for Herpes Zoster Ophthalmicus: clinical Insights from the ZEDS trial
Submission is temporarily unavailable. reCAPTCHA validation has not been configured yet.
Recipient e-mail
Separate email by comma. E.g. (
[email protected]
,
[email protected]
)
Name
E-mail
Message
Read in Portuguese
Print
PDF English
Share
▼
Send this article by email
Submit a comment
Mendeley
Pocket
Share on Facebook
Share on Twitter
Share on Linkedin
Share on WhatsApp
How to cite this article:
Costa
1 DC,
2. Low-dose valacyclovir for Herpes Zoster Ophthalmicus: clinical Insights from the ZEDS trial. Arq. Bras. Oftalmol. 2026;89(1): eRes22026v:1-2. 10.5935/0004-2749.eRes22026
Export citation
Dimensions
Altmetric
PlumX
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
